Follow-up Study After Investigator-Initiated Phase I Study of MTC001 for Chronic Ischemic Heart Failure.
Not Applicable
Recruiting
- Conditions
- Chronic ischemic heart failureD017202
- Registration Number
- JPRN-jRCT1030230216
- Lead Sponsor
- Machino Takeshi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
1)Patients who received VCF1 in the investigator-initiated phase 1 study (MTC001-2012) and who have consented to this observational study by the end of study participation (52 weeks).
2)Patients who are able to obtain written consent in person.
Exclusion Criteria
1)Patients who withdrew consent after receiving VCF1 in the investigator-initiated phase I study (MTC001-2012)
2)Patients deemed ineligible by the Principal Investigator or Sub investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of major cardiovascular events<br>*: Major cardiovascular events: death, myocardial infarction, stroke, hospitalization/prolonged hospitalization due to worsening heart failure, cardiac perforation, cardiac tamponade, sustained ventricular tachycardia (>30 seconds or hemodynamic collapse)/ventricular fibrillation among serious adverse events
- Secondary Outcome Measures
Name Time Method